Yposkesi sélectionné pour la Grande Exposition du Fabriqué en France à l’Elysée les 18 et 19 janvier 2020
Urania Therapeutics benefits from €1.7M Deeptech financing from Bpifrance
Domain Therapeutics secures €6 million ($6.7M) debt financing
Yposkesi selected to produce clinical and large-scale commercial material of micro-dystrophin for Genethon and Sarepta Therapeutics program
Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD
Alderaan Biotechnology raises €18.5M in Series A from Advent France Biotechnology (AFB) and Medicxi
Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ project at ADRIQ-RCTi Innovation Prize gala
Advent France Biotechnology participe au tour d’amorçage de 4,2 millions d’euros d’Augustine Therapeutics
